CAS 1256152-35-8
:FIIN-1
Description:
FIIN-1, with the CAS number 1256152-35-8, is a small molecule inhibitor primarily known for its role in targeting the protein kinase activity of certain enzymes, particularly those involved in cancer pathways. It is characterized by its ability to selectively inhibit the activity of specific kinases, which can lead to the suppression of tumor growth and proliferation. The compound is often studied in the context of cancer research, where it shows potential for therapeutic applications. FIIN-1 is typically described as having a complex molecular structure that includes various functional groups, contributing to its binding affinity and specificity. Its efficacy and safety profiles are subjects of ongoing research, with studies focusing on its pharmacokinetics, bioavailability, and potential side effects. As with many experimental compounds, further investigation is necessary to fully understand its mechanisms of action and therapeutic potential in clinical settings.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
FIIN-1
CAS:<p>FIIN-1 is a non-selective inhibitor of the epidermal growth factor receptor (EGFR). It binds to the EGFR and prevents it from binding with its ligands. This inhibition of EGFR prevents cellular proliferation, which can lead to cancer. FIIN-1 also inhibits the tyrosine kinase activity of the EGFR and therefore inhibits the phosphorylation of proteins that regulate cell growth. FIIN-1 is effective at inhibiting platelet-derived growth factors, such as PDGF, and other growth factors, such as EGF. The binding of FIIN-1 to the EGFR has been shown to inhibit tumor cell proliferation in vitro and in vivo.</p>Formula:C32H39Cl2N7O4Purity:Min. 95%Molecular weight:656.6 g/molFIIN-1
CAS:<p>FIIN-1 (FGFR irreversible inhibitor-1) is an irreversible and selective FGFR inhibitor with Kd of 2.8, 6.9, 5.4, 120, 32 and 120 nM for FGFR1, FGFR2, FGFR3,</p>Formula:C32H39Cl2N7O4Purity:98.75%Color and Shape:SolidMolecular weight:656.6
